VIR Biotechnology
UEI: VAGNEFK9N5X7
• CAGE: 80UV6
Overview
Awardee Type
Parent
(1 child)
Company Description
Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond.
Name
VIR Biotechnology
Website
Headquarters
San Francisco, CA
United States
United States
Most Recent Award
Nov. 1, 2023
Calculating
Federal contract and grant recipient
VIR BIOTECHNOLOGY, INC.
(UEI VAGNEFK9N5X7, CAGE 80UV6)
is headquartered in San Francisco CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in April 2016 and
federally registered in
December 2017.
Federal Award Analysis
VIR Biotechnology federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
VIR BIOTECHNOLOGY, INC.
Division Name
VIR BIOTECHNOLOGY INC
Division Number
VIR BIOTEC
UEI
VAGNEFK9N5X7
CAGE Code
80UV6
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 7, 2016
Initial Registration
Dec. 21, 2017
Last Registration
Oct. 18, 2024
Registration Activation
Oct. 18, 2024
Registration Expiration
Oct. 10, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at VIR Biotechnology
Contract Awards
VIR Biotechnology prime contract awards
Grant Awards
VIR Biotechnology direct grants
Subgrant Awards
VIR Biotechnology subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
VIR Biotechnology